Last updated: April 29, 2024
Sponsor: Radboud University Medical Center
Overall Status: Active - Recruiting
Phase
N/A
Condition
Williams Syndrome
Manic Disorders
Treatment
Multicomponent intervention program
Clinical Study ID
NCT05783505
2022-16133
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion criteria:
- Adult ICU patients (aged ≥18) with an expected ICU stay of >24 hours
- Patients who are (expected to become) agitated within the first 14 days of their ICUadmission
Exclusion
Exclusion criteria:
- Contra indication for dexmedetomidine use (i.e., AV-block grade 2 or 3 unless apacemaker is present, uncontrolled hypotension, acute cerebrovascular condition orknown/suspected hypersensitivity);
- Neurological patients with an (expected risk of) increased intracranial pressure;
- An intoxication as a result of drug abuse (e.g., ethanol, γ-Hydroxybutyrate, opioids,benzodiazepines);
- Support with Extracorporeal Membrane Oxygenation (ECMO);
- Difficult airway (e.g., a Cormack and Lehane laryngoscopy grade 4 view or a tumorcausing airway obstruction);
- A high risk of physical aggression towards healthcare professionals;
- No consent for long term follow up in the MONITOR-IC study;
- Not able to read or understand the Dutch language and no relatives able to assist;
- Enrolment in other sedation studies.
Study Design
Total Participants: 480
Treatment Group(s): 1
Primary Treatment: Multicomponent intervention program
Phase:
Study Start date:
June 01, 2023
Estimated Completion Date:
June 01, 2025
Study Description
Connect with a study center
Noordwest Ziekenhuisgroep
Alkmaar,
NetherlandsActive - Recruiting
Bravis Ziekenhuis
Bergen Op Zoom,
NetherlandsActive - Recruiting
Amphia Ziekenhuis
Breda,
NetherlandsActive - Recruiting
Zuyderland Ziekenhuis
Heerlen,
NetherlandsSite Not Available
Elkerliek Ziekenhuis
Helmond,
NetherlandsActive - Recruiting
VieCuri Medisch Centrum
Venlo,
NetherlandsActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.